(Q30157932)

8 June 2017

Anticalins: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies (English)

1 reference

8 June 2017

1 reference

2

0 references

author name string

Andreas M Hohlbaum

series ordinal

1

1 reference

PubMed ID

20477155

8 June 2017

language of work or name

1 reference

1 July 2007

1 reference

Expert Review of Clinical Immunology

8 June 2017

1 reference

8 June 2017

3

1 reference

8 June 2017

491-501

1 reference

8 June 2017

4

1 reference

Biopharmaceutical benchmarks 2006.

8 June 2017

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Potent antibody therapeutics by design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Cancer immunotherapy: a treatment for the masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Immune therapy for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Improving the efficacy of antibody-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Economic aspects of commercial manufacture of biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Imitating the humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Binding proteins from alternative scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Engineering novel binding proteins from nonimmunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Biopharmaceutical drug discovery using novel protein scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

21 January 2018

Lipocalins as a scaffold

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Comparative ligand-binding analysis of ten human lipocalins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Lipocalins in drug discovery: from natural ligand-binding proteins to "anticalins".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Solubility engineering and crystallization of human apolipoprotein D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Alpha-1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Purification, cloning, expression, and mechanism of action of a novel platelet aggregation inhibitor from the salivary gland of the blood-sucking bug, Rhodnius prolixus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Nitrophorins and related antihemostatic lipocalins from Rhodnius prolixus and other blood-sucking arthropods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Inhibition of hemostasis by a high affinity biogenic amine-binding protein from the saliva of a blood-feeding insect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

An iron delivery pathway mediated by a lipocalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

The 1.8-A crystal structure of human tear lipocalin reveals an extended branched cavity with capacity for multiple ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

The bilin-binding protein of Pieris brassicae. cDNA sequence and regulation of expression reveal distinct features of this insect pigment protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Rational engineering of a fluorescein-binding anticalin for improved ligand affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Structural mechanism of specific ligand recognition by a lipocalin tailored for the complexation of digoxigenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Antibody targeted drugs as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Arming antibodies: prospects and challenges for immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Molecular imaging of cancer with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Tailoring antibodies for radionuclide delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Monoclonal antibodies market.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Studies of the release and turnover of a human neutrophil lipocalin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Albumin binding as a general strategy for improving the pharmacokinetics of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Structure-immunogenicity relationships of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

Immunogenicity screening in protein drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

The validity of predicted T-cell epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

21 January 2018

Non-Antibody Scaffolds

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.4.491

21 January 2018

Identifiers

DOI

10.1586/1744666X.3.4.491

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hbuk5rg3irgq5kleowybcjvcre

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_hbuk5rg3irgq5kleowybcjvcre

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hbuk5rg3irgq5kleowybcjvcre

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/hbuk5rg3irgq5kleowybcjvcre